RaQualia Pharma Inc. (4579)
Market Closed
2 Oct, 06:00 AM
JPX JPX Primary ¥
609. 00
-23
-3.6392%
¥
22.11B Market Cap
- P/E Ratio
- Div Yield
157,900 Volume
- Eps
¥ 632
Previous Close Want to track 4579 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
RaQualia Pharma Inc. (4579) Statistics
Valuation metrics
Market Cap 22.11B
Enterprise value 14.22B
Trailing P/E (ttm) 69.16
Forward P/E 21.3
PEG ratio 3.38
Price/Sales (ttm) 4.13
Price/Book (mrq) 2.06
Enterprise Value/Revenue 3.65
Enterprise Value/EBITDA 16.8
Overview
Shares outstanding 24.46M
Float 17.4M
Shares short -
% Held by insiders 0.32%
% Held by institutions 0.02%
Average volume (10 days) 147.97K
Average volume (90 days) 134.45K
Price summary
52-Week low 438
52-Week high 1,465
Beta 0.94
50-Day moving average 574.04
200-Day moving average 589.36
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2025
Profitability
Profit margin 0.04%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.02%
Income Statement
Revenue (ttm) 3.98B
Revenue per share (ttm) 149.87
Quarterly revenue growth (yoy) 1.26%
Gross profit (ttm) 3.27B
EBITDA 958.96M
Net income to common (ttm) 273M
Diluted EPS (ttm) 6.2
Quarterly earnings growth (yoy) 0.18%
Balance Sheet
Total cash (mrq) 3.24B
Total cash per share (mrq) 180.49
Total debt (mrq) 2.9B
Total Debt/Equity (mrq) 0.34
Current ratio (mrq) 5.78%
Book value per share (mrq) 300.96
Cash Flow
Cash flow statement -354M
Levered free cash flow (LFCF) -485M
2026 © Marketlog. All Rights Reserved.
